BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 22130461)

  • 1. Correlation of Foxp3 positive regulatory T cells with prognostic factors in canine mammary carcinomas.
    Kim JH; Hur JH; Lee SM; Im KS; Kim NH; Sur JH
    Vet J; 2012 Jul; 193(1):222-7. PubMed ID: 22130461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intratumoral FoxP3 expression is associated with angiogenesis and prognosis in malignant canine mammary tumors.
    Carvalho MI; Pires I; Prada J; Gregório H; Lobo L; Queiroga FL
    Vet Immunol Immunopathol; 2016 Oct; 178():1-9. PubMed ID: 27496736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratumoral FOXP3 expression in infiltrating breast carcinoma: Its association with clinicopathologic parameters and angiogenesis.
    Gupta S; Joshi K; Wig JD; Arora SK
    Acta Oncol; 2007; 46(6):792-7. PubMed ID: 17653902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of FoxP3 expression to identify regulatory T cells in healthy dogs and dogs with cancer.
    Biller BJ; Elmslie RE; Burnett RC; Avery AC; Dow SW
    Vet Immunol Immunopathol; 2007 Mar; 116(1-2):69-78. PubMed ID: 17224188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients.
    Fu J; Xu D; Liu Z; Shi M; Zhao P; Fu B; Zhang Z; Yang H; Zhang H; Zhou C; Yao J; Jin L; Wang H; Yang Y; Fu YX; Wang FS
    Gastroenterology; 2007 Jun; 132(7):2328-39. PubMed ID: 17570208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD8⁺ cytotoxic T cell and FOXP3⁺ regulatory T cell infiltration in relation to breast cancer survival and molecular subtypes.
    Liu F; Lang R; Zhao J; Zhang X; Pringle GA; Fan Y; Yin D; Gu F; Yao Z; Fu L
    Breast Cancer Res Treat; 2011 Nov; 130(2):645-55. PubMed ID: 21717105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity, expression of adipocytokines, and macrophage infiltration in canine mammary tumors.
    Lim HY; Im KS; Kim NH; Kim HW; Shin JI; Sur JH
    Vet J; 2015 Mar; 203(3):326-31. PubMed ID: 25641553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-8 as a prognostic serum marker in canine mammary gland neoplasias.
    Gelaleti GB; Jardim BV; Leonel C; Moschetta MG; Zuccari DA
    Vet Immunol Immunopathol; 2012 Apr; 146(2):106-12. PubMed ID: 22405680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding of the immunological heterogeneity of canine mammary carcinomas to provide immunophenotypic features of circulating leukocytes as clinically relevant prognostic biomarkers.
    Estrela-Lima A; Araújo MS; da Costa-Neto JM; Ribeiro LG; Damasceno KA; D'Assis MJ; Martins-Filho OA; Teixeira-Carvalho A; Serakides R; Cassali GD
    Breast Cancer Res Treat; 2012 Feb; 131(3):751-63. PubMed ID: 21448671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and prognostic significance of CK19 in canine malignant mammary tumours.
    Gama A; Alves A; Schmitt F
    Vet J; 2010 Apr; 184(1):45-51. PubMed ID: 19264518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated expression of Foxp3 in tumor-infiltrating Treg cells suppresses T-cell proliferation and contributes to gastric cancer progression in a COX-2-dependent manner.
    Yuan XL; Chen L; Li MX; Dong P; Xue J; Wang J; Zhang TT; Wang XA; Zhang FM; Ge HL; Shen LS; Xu D
    Clin Immunol; 2010 Mar; 134(3):277-88. PubMed ID: 19900843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skin melanoma development in ret transgenic mice despite the depletion of CD25+Foxp3+ regulatory T cells in lymphoid organs.
    Kimpfler S; Sevko A; Ring S; Falk C; Osen W; Frank K; Kato M; Mahnke K; Schadendorf D; Umansky V
    J Immunol; 2009 Nov; 183(10):6330-7. PubMed ID: 19841169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin 2-mediated conversion of ovarian cancer-associated CD4+ regulatory T cells into proinflammatory interleukin 17-producing helper T cells.
    Leveque L; Deknuydt F; Bioley G; Old LJ; Matsuzaki J; Odunsi K; Ayyoub M; Valmori D
    J Immunother; 2009; 32(2):101-8. PubMed ID: 19238008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of CD4+CD25+ regulatory T cells may underlie enhanced Th1 immunity caused by immunization with activated autologous T cells.
    Cao Q; Wang L; Du F; Sheng H; Zhang Y; Wu J; Shen B; Shen T; Zhang J; Li D; Li N
    Cell Res; 2007 Jul; 17(7):627-37. PubMed ID: 17563757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intratumoral forkhead box P3-positive regulatory T cells predict poor survival in cyclooxygenase-2-positive uveal melanoma.
    Mougiakakos D; Johansson CC; Trocme E; All-Ericsson C; Economou MA; Larsson O; Seregard S; Kiessling R
    Cancer; 2010 May; 116(9):2224-33. PubMed ID: 20209608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo expansion of CD4+Foxp3+ regulatory T cells mediated by GITR molecules.
    Nishioka T; Nishida E; Iida R; Morita A; Shimizu J
    Immunol Lett; 2008 Dec; 121(2):97-104. PubMed ID: 18930767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of regulatory T cells in patients with B-cell chronic lymphocytic leukemia.
    Giannopoulos K; Schmitt M; Kowal M; Wlasiuk P; Bojarska-Junak A; Chen J; Rolinski J; Dmoszynska A
    Oncol Rep; 2008 Sep; 20(3):677-82. PubMed ID: 18695923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer.
    Salama P; Phillips M; Grieu F; Morris M; Zeps N; Joseph D; Platell C; Iacopetta B
    J Clin Oncol; 2009 Jan; 27(2):186-92. PubMed ID: 19064967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infiltrating Foxp3+ regulatory T cells and histopathological features in canine classical and spermatocytic seminomas.
    Kim JH; Chon SK; Im KS; Kim NH; Cho KW; Sur JH
    Reprod Domest Anim; 2013 Apr; 48(2):218-22. PubMed ID: 22775571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accumulation of regulatory T cells in sentinel lymph nodes is a prognostic predictor in patients with node-negative breast cancer.
    Nakamura R; Sakakibara M; Nagashima T; Sangai T; Arai M; Fujimori T; Takano S; Shida T; Nakatani Y; Miyazaki M
    Eur J Cancer; 2009 Aug; 45(12):2123-31. PubMed ID: 19398324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.